Deutsche Wohnen FY21 FFO I Rises, Gross Rental Income Stable - Quick Facts

Deutsche Wohnen SE (DWHHF.PK), a German property company majority owned by Vonovia SE, on Friday reported that fiscal 2021 Funds from operations or FFO I was 553.6 million euros, up 2.4 percent from last year.

FFO I per share was 1.54 euros, in line with the company's forecast.

Annual earnings fell to 919.0 million euros, mainly because of lower earnings from disposals and one-off, transaction-related expenses.

The adjusted EBITDA, without disposals, grew 1.6 percent to 715.8 million euros from last year's 704.8 million euros.

Deutsche Wohnen generated a stable gross rental income of 843.6 million euros despite reducing its property holdings due to disposals.

The revaluation of the portfolio led to an increase in the Net Asset Value or NAV to 21.59 billion euros. This corresponds to a NAV per share of 54.39 euros, up 4.7 percent compared to the previous year.

The company plans to publish the consolidated annual financial statements for the financial year 2021 on March 31.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
United Airlines and Archer Aviation Inc. announced plans to launch the first commercial electric air taxi route in Chicago, between O'Hare International Airport or ORD and Vertiport Chicago. As part of their urban air mobility or UAM network buildout, both companies will utilize Archer's electric vertical takeoff and landing or eVTOL aircraft in the new route. Fort Wayne, Indiana-based Perfection Bakeries D/B/A Aunt Millie's is recalling 8 ct. packages of Our Family White Hot Dog Buns citing the possible presence of undeclared sesame, a known allergen, the U.S. Food and Drug Administration said. The product comes in a printed plastic package marked with "Our Family Hot Dog Buns 8 ct." on the top and has a blue twist tie. Parsippany, New Jersey -based Ascend Laboratories LLC. is recalling Dabigatran Etcxilate capsules citing the detection of N-Nitrosodimethylamine or NDMA impurity, a probable human carcinogen, the U.S. Food and Drug Administration said. The product is used as an oral anticoagulant to lower the risk of stroke and blood clots.
Follow RTT